157 related articles for article (PubMed ID: 22222334)
21. Molecular determinants of differential sensitivity to docetaxel and paclitaxel in human pediatric cancer models.
Izbicka E; Campos D; Marty J; Carrizales G; Mangold G; Tolcher A
Anticancer Res; 2006; 26(3A):1983-8. PubMed ID: 16827133
[TBL] [Abstract][Full Text] [Related]
22. 18F-FPPRGD2 and 18F-FDG PET of response to Abraxane therapy.
Sun X; Yan Y; Liu S; Cao Q; Yang M; Neamati N; Shen B; Niu G; Chen X
J Nucl Med; 2011 Jan; 52(1):140-6. PubMed ID: 21149494
[TBL] [Abstract][Full Text] [Related]
23. Isolation and purification of psoralen and isopsoralen and their efficacy and safety in the treatment of osteosarcoma in nude rats.
Lu H; Zhang L; Liu D; Tang P; Song F
Afr Health Sci; 2014 Sep; 14(3):641-7. PubMed ID: 25352883
[TBL] [Abstract][Full Text] [Related]
24. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.
Peterson JK; Tucker C; Favours E; Cheshire PJ; Creech J; Billups CA; Smykla R; Lee FY; Houghton PJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6950-8. PubMed ID: 16203787
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells.
Kubo T; Shimose S; Matsuo T; Sakai A; Ochi M
Cancer Chemother Pharmacol; 2008 Jun; 62(1):111-6. PubMed ID: 17874104
[TBL] [Abstract][Full Text] [Related]
26. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.
Desai N; Trieu V; Yao Z; Louie L; Ci S; Yang A; Tao C; De T; Beals B; Dykes D; Noker P; Yao R; Labao E; Hawkins M; Soon-Shiong P
Clin Cancer Res; 2006 Feb; 12(4):1317-24. PubMed ID: 16489089
[TBL] [Abstract][Full Text] [Related]
27. Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo.
Wang Y; Fu Q; Zhao W
Mol Med Rep; 2013 Oct; 8(4):984-8. PubMed ID: 23912183
[TBL] [Abstract][Full Text] [Related]
28. Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.
Suto R; Abe Y; Nakamura M; Ohnishi Y; Yoshimura M; Lee YH; Imanishi T; Yamazaki H; Kijima H; Tokunaga T; Oshika Y; Hiraoka N; Tamaoki N; Fukuda H; Ueyama Y
Int J Oncol; 1998 Feb; 12(2):287-91. PubMed ID: 9458350
[TBL] [Abstract][Full Text] [Related]
29. CTGF increases drug resistance to paclitaxel by upregulating survivin expression in human osteosarcoma cells.
Tsai HC; Huang CY; Su HL; Tang CH
Biochim Biophys Acta; 2014 May; 1843(5):846-54. PubMed ID: 24462773
[TBL] [Abstract][Full Text] [Related]
30. A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases.
Ernsting MJ; Murakami M; Undzys E; Aman A; Press B; Li SD
J Control Release; 2012 Sep; 162(3):575-81. PubMed ID: 22967490
[TBL] [Abstract][Full Text] [Related]
31. Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane.
Feng Z; Zhao G; Yu L; Gough D; Howell SB
Cancer Chemother Pharmacol; 2010 Apr; 65(5):923-30. PubMed ID: 19685054
[TBL] [Abstract][Full Text] [Related]
32. Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft.
Luo FR; Yang Z; Dong H; Camuso A; McGlinchey K; Fager K; Flefleh C; Kan D; Inigo I; Castaneda S; Rose WC; Kramer RA; Wild R; Lee FY
Cancer Chemother Pharmacol; 2005 Nov; 56(5):455-64. PubMed ID: 15947929
[TBL] [Abstract][Full Text] [Related]
33. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
Lu S; Zhang J; Zhou Z; Liao ML; He WZ; Zhou XY; Li ZM; Xiang JQ; Wang JJ; Chen HQ
Oncol Rep; 2008 Sep; 20(3):581-7. PubMed ID: 18695909
[TBL] [Abstract][Full Text] [Related]
34. PCR and flow cytometric analysis of paclitaxel-inhibited arylamine N-acetyltransferase activity and gene expression in human osteogenic sarcoma cells (U-2 OS).
Lu KH; Wang DY; Lue KH; Hsiao YM; Chou MC; Chen YS; Chung JG
Anticancer Res; 2004; 24(1):83-90. PubMed ID: 15015580
[TBL] [Abstract][Full Text] [Related]
35. Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer.
Eigl BJ; Eggener SE; Baybik J; Ettinger S; Chi KN; Nelson C; Wang Z; Gleave ME
Clin Cancer Res; 2005 Jul; 11(13):4905-11. PubMed ID: 16000589
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel induces apoptosis via caspase-3 activation in human osteogenic sarcoma cells (U-2 OS).
Lu KH; Lue KH; Chou MC; Chung JG
J Orthop Res; 2005 Sep; 23(5):988-94. PubMed ID: 16140185
[TBL] [Abstract][Full Text] [Related]
37. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.
Maschek G; Savaraj N; Priebe W; Braunschweiger P; Hamilton K; Tidmarsh GF; De Young LR; Lampidis TJ
Cancer Res; 2004 Jan; 64(1):31-4. PubMed ID: 14729604
[TBL] [Abstract][Full Text] [Related]
38. Dexamethasone inhibits the effect of paclitaxel on human ovarian carcinoma xenografts in nude mice.
Hou WJ; Guan JH; Dong Q; Han YH; Zhang R
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2902-8. PubMed ID: 24254559
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
[TBL] [Abstract][Full Text] [Related]
40. Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer.
Sirotnak FM; She Y; Lee F; Chen J; Scher HI
Clin Cancer Res; 2002 Dec; 8(12):3870-6. PubMed ID: 12473602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
